Concepedia

Matthew Boron

MB

Statistics

Publications

4

Citations

517

H-Index

4

Active since

2004

Affiliations

National Cancer Institute(Current)

University of Pennsylvania

Children's Hospital of Philadelphia

Matthew Boron is an author at National Cancer Institute specializing in chemotherapy, pharmacology, and pharmacotherapy.

Publications per year

2004–2023

4

Publications

4

Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients With Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301

Helen X. Chen, Margaret Mooney, Matthew Boron et al. · Journal of Clinical Oncology · 2006 · 186 citations

, , +11

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Brigitte C. Widemann, Frank M. Balis, AeRang Kim et al. · Journal of Clinical Oncology · 2010 · 173 citations · Full text

, , +17

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Steven G. DuBois, Mark Krailo, Julia Glade Bender et al. · Journal of Clinical Oncology · 2023 · 87 citations · Full text

, , +17

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G2

Brigitte C. Widemann, Frank M. Balis, Aiman Shalabi et al. · JNCI Journal of the National Cancer Institute · 2004 · 71 citations · Full text

, , +13

1–4 of 4